BETHLEHEM, Pa. & PLYMOUTH, Minn.--(BUSINESS WIRE)--January 29, 2009--Invatec, a comprehensive innovator of interventional products, today announced that it has entered a worldwide distribution agreement with Lumen Biomedical, Inc. to distribute the FiberNet ® Embolic Protection System (EPS). The FiberNet EPS, which received FDA clearance in November, is indicated for the treatment of patients receiving endovascular intervention for carotid artery disease. The product has also received CE Mark approval for use during carotid and saphenous vein graft (SVG) procedures.
Full article >> http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090129005116&newsLang=en
Saturday, January 31, 2009
Invatec Announces Worldwide Distribution Agreement with Lumen Biomedical
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment